VINCERX PHARMA INCVINCERX PHARMA INCVINCERX PHARMA INC

VINCERX PHARMA INC

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪1.44 M‬USD
−19.5628USD
‪−30.07 M‬USD
0.00USD
‪4.49 M‬
Beta (1Y)
−1.15
Employees (FY)
13
Change (1Y)
−29 −69.05%
Revenue / Employee (1Y)
Net income / Employee (1Y)

About VINCERX PHARMA INC


Headquarters
San Mateo
Founded
2018
FIGI
BBG00RRQXMX2
Vincerx Pharma, Inc. operates as a clinical-stage biopharmaceutical company which develops antibody drugs. It focuses on leveraging its extensive development and oncology expertise to advance new therapies intended to address unmet medical needs for the treatment of cancer. The firm pipeline is derived from a license agreement with Bayer and includes: a clinical-stage and follow-on small molecule drug program and preclinical stage bioconjugation/next-generation antibody-drug conjugate platform. The company was founded by Ahmed M. Hamdy, Raquel E. Izumi, Tom C. Thomas, Soo In Hwang and John C. Byrd on December 19, 2018 and is headquartered in Palo Alto, CA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:

See all ideas 

Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as VINC.

Frequently Asked Questions


The current price of VINC is 0.1720 USD — it has decreased by −37.45% in the past 24 hours. Watch VINCERX PHARMA INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange VINCERX PHARMA INC stocks are traded under the ticker VINC.
VINC stock has fallen by −33.85% compared to the previous week, the month change is a −71.38% fall, over the last year VINCERX PHARMA INC has showed a −99.02% decrease.
VINC stock is 70.49% volatile and has beta coefficient of −1.15. Track VINCERX PHARMA INC stock price on the chart and check out the list of the most volatile stocks — is VINCERX PHARMA INC there?
Yes, you can track VINCERX PHARMA INC financials in yearly and quarterly reports right on TradingView.
VINCERX PHARMA INC is going to release the next earnings report on May 8, 2025. Keep track of upcoming events with our Earnings Calendar.
VINC net income for the last quarter is ‪−7.99 M‬ USD, while the quarter before that showed ‪−7.84 M‬ USD of net income which accounts for −1.93% change. Track more VINCERX PHARMA INC financial stats to get the full picture.
No, VINC doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Apr 21, 2025, the company has 13 employees. See our rating of the largest employees — is VINCERX PHARMA INC on this list?
Like other stocks, VINC shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade VINCERX PHARMA INC stock right from TradingView charts — choose your broker and connect to your account.